Central Admixture Pharmacy Services Inc recalls fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 100 mL, Total FentaNYL 200 mcg/100 m
Recalled August 9, 2023 · FDA recall D-1070-2023 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility: Lack of validation data for sanitization cycles · FDA Class II
Units
1,114 bags
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Product
fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 100 mL, Total FentaNYL 200 mcg/100 mL, 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-1
Manufacturer(s)
Central Admixture Pharmacy Services Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →